top of page

Oncura Health at ASCO 2026: Advancing Research, Expanding Access

  • Writer: Oncura Health
    Oncura Health
  • May 29
  • 2 min read

Each year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together the world’s leading minds in cancer research and care. It’s where the latest breakthroughs are shared, new ideas take shape and the future of oncology begins to unfold.


This year, Oncura Health is proud to be part of that conversation.


Three smiling men in suits take a selfie at an ASCO conference hall, with crowds and directional signs in the background.
Dr. Ronald Tang, Dr. Lasika Seneviratne, and Dr. Eric Lee

Representing Oncura Health on a Global Stage

Members of our physician and research leadership team—Dr. Ronald Tang, Dr. Lasika Seneviratne, and Dr. Eric Lee—are attending the 2026 ASCO Annual Meeting to engage with peers, explore emerging therapies and identify new opportunities that can directly benefit the patients we serve.


Their presence at ASCO reflects our ongoing commitment to staying at the forefront of cancer care; bringing the latest advancements and insights back to our communities.


Recognizing Research Leadership at ASCO 2026

We are especially proud to recognize Dr. Ronald Tang, a board-certified medical oncologist at Oncura Health, who is a named author and principal investigator associated with the COPERNICUS Phase 2b study.


This study is evaluating subcutaneous amivantamab in combination with chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer—a promising area of research that may expand treatment options for patients facing this diagnosis.


Dr. Tang’s involvement highlights the important role Oncura Health physicians play in advancing clinical research and contributing to the development of next-generation cancer therapies.


ASCO Presentation Details

The COPERNICUS study poster will be presented at ASCO:

📅 Sunday, May 31, 2026

🕘 9:00 AM – 12:00 PM CDT

📍 Hall A | Poster Board 404


Turning Research Into Real-World Impact

At Oncura Health, research is not separate from care. It’s an extension of it.


Our participation in ASCO reflects a broader commitment to:

  • advancing innovative cancer treatments

  • strengthening industry and research partnerships

  • expanding access to clinical trials

  • bringing cutting-edge care closer to where our patients live


By staying actively involved in clinical research, we help ensure that our patients have access to the most current and promising treatment options available.


Looking Ahead

The conversations and discoveries that take place at ASCO don’t stay there. They shape the future of cancer care.


We’re proud to have Oncura Health physicians contributing to that progress and helping translate innovation into meaningful outcomes for patients and families.


Committed to What’s Next

At Oncura Health, we believe that progress in cancer care should be accessible. Not distant.


Through continued research, collaboration and clinical excellence, we are working to bring tomorrow’s treatments to today’s patients.

Comments


bottom of page